Advertisement
Screener

BIONIK LABORATORIES CORP. Accretion Expense

BIONIK LABORATORIES CORP. Accretion Expense

BIONIK LABORATORIES CORP. reported Accretion Expense of $0 for the 12-month period ending 2020-03-31, per its 10-K filed 2020-06-29.

Discontinued › Expense Statement › Operating Expenses

us-gaap:AccretionExpense · last filed 2020-06-29

  • BIONIK LABORATORIES CORP. accretion expense for the quarter ending 2020-03-31 was $0.00, a 100.00% decline year-over-year.
  • BIONIK LABORATORIES CORP. accretion expense for the quarter ending 2019-12-31 was $0.00, a 100.00% decline year-over-year.
  • BIONIK LABORATORIES CORP. accretion expense for the quarter ending 2019-09-30 was $0.00, a 100.00% decline year-over-year.
  • BIONIK LABORATORIES CORP. accretion expense for the quarter ending 2019-06-30 was $0.00, a 100.00% decline year-over-year.
  • BIONIK LABORATORIES CORP. accretion expense for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
  • BIONIK LABORATORIES CORP. accretion expense for fiscal 2019 was $3.27M, a 68.63% increase from fiscal 2018.
  • BIONIK LABORATORIES CORP. accretion expense for fiscal 2018 was $1.94M.
  • BIONIK LABORATORIES CORP. accretion expense for fiscal 2017 was $0.00.
Period endAccretion Expense 1 monthAccretion Expense 3 monthAccretion Expense 6 monthAccretion Expense 9 monthAccretion Expense 12 month
2020-03-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2020-06-29
$0.00
derived: sum of 2 quarters · filed 2020-06-29
$0.00
derived: sum of 3 quarters · filed 2020-06-29
$0.00
10-K · filed 2020-06-29
2019-12-31$0.00
10-Q · filed 2020-02-14
$0.00
derived: sum of 2 quarters · filed 2020-02-14
$0.00
10-Q · filed 2020-02-14
$845.86K
derived: sum of 4 quarters · filed 2020-06-29
2019-09-30$0.00
10-Q · filed 2019-11-14
$0.00
10-Q · filed 2019-11-14
$845.86K
derived: sum of 3 quarters · filed 2020-06-29
$1.16M
derived: sum of 4 quarters · filed 2020-06-29
2019-06-30$0.00
10-Q · filed 2019-08-12
$845.86K
derived: sum of 2 quarters · filed 2020-06-29
$1.16M
derived: sum of 3 quarters · filed 2020-06-29
$3.13M
derived: sum of 4 quarters · filed 2020-06-29
2019-03-31$845.86K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-06-29
$1.16M
derived: sum of 2 quarters · filed 2020-06-29
$3.13M
derived: sum of 3 quarters · filed 2020-06-29
$3.27M
10-K · filed 2019-07-01
2019-03-28$1.16M
10-K · filed 2019-07-01
2018-12-31$316.64K
10-Q · filed 2020-02-14
$2.29M
derived: sum of 2 quarters · filed 2020-02-14
$2.42M
10-Q · filed 2020-02-14
$4.07M
derived: sum of 4 quarters · filed 2020-02-14
2018-09-30$1.97M
10-Q · filed 2019-11-14
$2.10M
10-Q · filed 2019-11-14
$3.75M
derived: sum of 3 quarters · filed 2019-11-14
$3.97M
derived: sum of 4 quarters · filed 2019-11-14
2018-06-30$134.25K
10-Q · filed 2019-08-12
$1.78M
derived: sum of 2 quarters · filed 2019-08-12
$2.00M
derived: sum of 3 quarters · filed 2019-08-12
$2.07M
derived: sum of 4 quarters · filed 2019-08-12
2018-03-31$1.65M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-07-01
$1.86M
derived: sum of 2 quarters · filed 2019-07-01
$1.94M
derived: sum of 3 quarters · filed 2019-07-01
$1.94M
10-K · filed 2019-07-01
2017-12-31$216.30K
10-Q · filed 2019-02-11
$290.38K
derived: sum of 2 quarters · filed 2019-02-11
$290.38K
10-Q · filed 2019-02-11
$290.38K
derived: sum of 4 quarters · filed 2019-02-11
2017-09-30$74.07K
10-Q · filed 2018-11-13
$74.07K
10-Q · filed 2018-11-13
$74.07K
derived: sum of 3 quarters · filed 2018-11-13
$74.07K
derived: sum of 4 quarters · filed 2018-11-13
2017-06-30$0.00
10-Q · filed 2018-08-14
$0.00
derived: sum of 2 quarters · filed 2018-08-14
$0.00
derived: sum of 3 quarters · filed 2018-08-14
$0.00
derived: sum of 4 quarters · filed 2018-08-14
2017-03-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2018-06-27
$0.00
derived: sum of 2 quarters · filed 2018-06-27
$0.00
derived: sum of 3 quarters · filed 2018-06-27
$0.00
10-K · filed 2018-06-27
2016-12-31$0.00
10-Q · filed 2018-02-13
$0.00
derived: sum of 2 quarters · filed 2018-02-13
$0.00
10-Q · filed 2018-02-13
2016-09-30$0.00
10-Q · filed 2017-11-13
$0.00
10-Q · filed 2017-11-13